The undesirable effects of neuromuscular blocking drugs
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
The undesirable effects of neuromuscular blocking drugs. / Claudius, C; Garvey, L H; Viby-Mogensen, J.
I: Anaesthesia, Bind 64 Suppl 1, 2009, s. 10-21.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The undesirable effects of neuromuscular blocking drugs
AU - Claudius, C
AU - Garvey, L H
AU - Viby-Mogensen, J
N1 - Keywords: Anesthesia Recovery Period; Drug Hypersensitivity; Humans; Neuromuscular Blockade; Neuromuscular Blocking Agents; Neuromuscular Junction
PY - 2009
Y1 - 2009
N2 - Neuromuscular blocking drugs are designed to bind to the nicotinic receptor at the neuromuscular junction. However, they also interact with other acetylcholine receptors in the body. Binding to these receptors causes adverse effects that vary with the specificity for the cholinergic receptor in question. Moreover, all neuromuscular blocking drugs may cause hypersensitivity reactions. Often the symptoms are mild and self-limiting but massive histamine release can cause systematic reactions with circulatory and respiratory symptoms and signs. At the end of anaesthesia, no residual effect of a neuromuscular blocking drug should be present. However, the huge variability in response to neuromuscular blocking drugs makes it impossible to predict which patient will suffer postoperative residual curarization. This article discusses the undesirable effects of the currently available neuromuscular blocking drugs including the definitions, diagnosis and causes of hypersensitivity reactions and postoperative residual curarisation.
AB - Neuromuscular blocking drugs are designed to bind to the nicotinic receptor at the neuromuscular junction. However, they also interact with other acetylcholine receptors in the body. Binding to these receptors causes adverse effects that vary with the specificity for the cholinergic receptor in question. Moreover, all neuromuscular blocking drugs may cause hypersensitivity reactions. Often the symptoms are mild and self-limiting but massive histamine release can cause systematic reactions with circulatory and respiratory symptoms and signs. At the end of anaesthesia, no residual effect of a neuromuscular blocking drug should be present. However, the huge variability in response to neuromuscular blocking drugs makes it impossible to predict which patient will suffer postoperative residual curarization. This article discusses the undesirable effects of the currently available neuromuscular blocking drugs including the definitions, diagnosis and causes of hypersensitivity reactions and postoperative residual curarisation.
U2 - 10.1111/j.1365-2044.2008.05866.x
DO - 10.1111/j.1365-2044.2008.05866.x
M3 - Journal article
C2 - 19222427
VL - 64 Suppl 1
SP - 10
EP - 21
JO - Anaesthesia
JF - Anaesthesia
SN - 0003-2409
ER -
ID: 19952241